000 discomfort professionals.

2014 PAINWeekEnd Regional Meeting to highlight health crises of inadequate discomfort management There are 116 million people in pain http://genericsildenafil.org . There are 4,000 discomfort professionals. That's 29,000 patients per pain specialist. There are simply not enough pain specialists to bypass. What can frontline practitioners do to meet the challenges of the growing public health issue? Attend PAINWeekEnd Houston! On Saturday The 2014 PAINWeekEnd Regional Conference convenes, May 10, in Houston at the Marriott Houston Westchase. Currently, the state of Texas mandates up to 10 credits in pain management as an element of the annual requirement of licensure reregistration. PAINWeekEnd attendees can receive 6. Course topics are the fundamentals of pain and addiction; opioid conversions; opioid-induced hyperalgesia; and special factors for methadone therapy.

The Asklepios researchers plan to insert a proprietary miniaturized edition of the dystrophin gene into an adeno-connected viral vector made to deliver the gene to human being muscles. MDA-funded experts at the University of Florida in Gainesville are developing approaches for gene therapy of limb-girdle MD in parallel with the Asklepios DMD research.. $1.6 million to develop gene therapy strategies for Duchenne muscular dystrophy, a fatal, childhood-onset disease The Muscular Dystrophy Association has announced it has awarded $1.6 million to Asklepios, a biotechnology company closely allied with the University of North Carolina at Chapel Hill, to develop gene therapy approaches for Duchenne muscular dystrophy , a fatal, childhood-onset disease.